-
Hogan DF, Brainard BM. Cardiogenic embolism in the cat. J Vet Cardiol. 2015;17(Suppl 1):S202-S214.
-
Lake-Bakaar GA, Johnson EG, Griffiths LG. Aortic thrombosis in dogs: 31 cases (2000-2010). JAVMA. 2012;241(7):910-915.
-
Respess M, O’Toole TE, Taeymans O, Rogers CL, Johnston A, Webster CR. Portal vein thrombosis in 33 dogs: 1998-2011. JVIM. 2012;26(2):230-237.
-
Hogan DF, Fox PR, Jacob K, et al. Secondary prevention of cardiogenic arterial thromboembolism in the cat: the double-blind, randomized, positive-controlled feline arterial thromboembolism; clopidogrel vs. aspirin trial (FAT CAT). J Vet Cardiol. 2015;17(Suppl 1):S306-S317.
-
Mellett AM, Nakamura RK, Bianco D. A prospective study of clopidogrel therapy in dogs with primary immune-mediated hemolytic anemia. JVIM. 2011;25(1):71-75.
-
Hogan DF, Andrews DA, Green HW III, Talbott KK, Ward MP, Calloway BM. Antiplatelet effects and pharmacodynamics of clopidogrel in cats. JAVMA. 2004;225(9):1406-1411.
-
Goodwin JC, Hogan DF, Green HW III. The pharmacodynamics of clopidogrel in the dog (abstract). JVIM. 2007;21(3):609.
-
Giustino G, Baber U, Sartori S, et al. Duration of dual antiplatelet therapy after drug-eluting stent implantation: a systematic review and meta-analysis of randomized controlled trials. J Am Coll Cardiol. 2015;65(13):1298-1310.
-
Kim S, Kunapuli SP. P2Y12 receptor in platelet activation. Platelets. 2011;22(1):56-60.
-
Mega JL, Simon T. Pharmacology of antithrombotic drugs: an assessment of oral antiplatelet and anticoagulant treatments. Lancet. 2015;386(9990):281-291.
-
Goodwin JC, Hogan DF, Green HW III. Altered hepatic metabolism of clopidogrel in dogs with inducers and inhibitors of hepatic enzymes (abstract). JVIM. 2007;21(3):609-610.
-
Blois SL, Lang ST, Wood RD, Monteith G. Biologic variability and correlation of platelet function testing in healthy dogs. Vet Clin Pathol. 2015;44(4):503-510.
-
Melloni C, Washam JB, Jones WS, et al. Conflicting results between randomized trials and observational studies on the impact of proton pump inhibitors on cardiovascular events when coadministered with dual antiplatelet therapy. Circ Cardiovasc Qual Outcome. 2015;8(1):47-55.
-
Bouziana SD, Tziomalos K. Clinical relevance of clopidogrel-proton pump inhibitors interaction. World J Gastrointest Pharmacol Ther. 2015;6(2):17-21.
-
Bhatt DL, Cryer BL, Contant CF, et al. Clopidogrel with or without omeprazole in coronary artery disease. N Engl J Med. 2010;363(2);1909-1917.
-
Thames BE, Lovvorn J, Papich MG, et al. The effects of clopidogrel and omeprazole on platelet function in normal dogs. J Vet Pharmacol Ther. 2016. doi: 10.1111/jvp.12340.
-
Yusuf S, Zhao F, Mehta SR, et al. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med. 2001;345(7):494-502.